Next Article in Journal
Antimicrobial Peptides (AMPs) in the Pathogenesis of Alzheimer’s Disease: Implications for Diagnosis and Treatment
Next Article in Special Issue
Clostridioides difficile in Food-Producing Animals in Romania: First Study on the Prevalence and Antimicrobial Resistance
Previous Article in Journal
Chemical Composition of Essential Oils of Bulbs and Aerial Parts of Two Cultivars of Allium sativum and Their Antibiofilm Activity against Food and Nosocomial Pathogens
Previous Article in Special Issue
Occurrence, Pathogenic Potential and Antimicrobial Resistance of Escherichia coli Isolated from Raw Milk Cheese Commercialized in Banat Region, Romania
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence, Antibiotic-Resistance, and Replicon-Typing of Salmonella Strains among Serovars Mainly Isolated from Food Chain in Marche Region, Italy

by
Ilaria Russo
1,
Daniela Bencardino
1,
Maira Napoleoni
2,
Francesca Andreoni
1,
Giuditta Fiorella Schiavano
3,
Giulia Baldelli
1,
Giorgio Brandi
1 and
Giulia Amagliani
1,*
1
Department of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy
2
Istituto Zooprofilattico Sperimentale dell’Umbria e Delle Marche “Togo Rosati”, 06126 Perugia, Italy
3
Department of Humanities, University of Urbino Carlo Bo, 61029 Urbino, Italy
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(6), 725; https://doi.org/10.3390/antibiotics11060725
Submission received: 9 May 2022 / Revised: 24 May 2022 / Accepted: 25 May 2022 / Published: 28 May 2022
(This article belongs to the Special Issue Food-Borne Pathogens and Antimicrobial Resistance)

Abstract

:
Nontyphoidal salmonellosis (NTS) is the second most commonly reported gastrointestinal infection in humans and an important cause of food-borne outbreaks in Europe. The use of antimicrobial agents for animals, plants, and food production contributes to the development of antibiotic-resistant Salmonella strains that are transmissible to humans through food. The aim of this study was to investigate the presence and the potential dissemination of multidrug-resistant (MDR) Salmonella strains isolated in the Marche Region (Central Italy) via the food chain. Strains were isolated from different sources: food, human, food animal/livestock, and the food-processing environment. Among them, we selected MDR strains to perform their further characterization in terms of resistance to tetracycline agent, carriage of tet genes, and plasmid profiles. Tetracycline resistance genes were detected by PCR and plasmid replicons by PCR-based replicon typing (PBRT). A total of 102 MDR Salmonella strains were selected among the most prevalent serovars: S. Infantis (n = 36/102), S. Derby (n = 20/102), S. Typhimurium (n = 18/102), and a monophasic variant of S. Typhimurium (MVST, n = 28/102). Resistance to sulfisoxazole (86%) and tetracycline (81%) were the most common, followed by ampicillin (76%). FIIS was the most predominant replicon (17%), followed by FII (11%) and FIB (11%) belonging to the IncF incompatibility group. Concerning the characterization of tet genes, tetB was the most frequently detected (27/89), followed by tetA (10/89), tetG (5/89), and tetM (1/89). This study showed the potential risk associated with the MDR Salmonella strains circulating along the food chain. Hence, epidemiological surveillance supported by molecular typing could be a very useful tool to prevent transmission of resistant Salmonella from food to humans, in line with the One Health approach.

1. Introduction

Nontyphoidal salmonellosis (NTS) is a common infection mainly caused by the ingestion of food or beverages contaminated by several zoonotic serovars with the potential to interact with human and animal hosts [1,2]. The most prevalent serovars responsible for human illnesses acquired in the European Union during 2019 were, in decreasing order, S. Infantis, S. Enteritidis, the monophasic variant of S. Typhimurium (MVST), S. Typhimurium, and S. Derby [3].
Food-producing livestock and domestic pets are most often sources of NTS food-borne outbreaks [1]. Indeed, NTS is linked to the consumption of Salmonella-contaminated food mostly from poultry, pork, and egg products. However, in the last few decades, the sporadic occurrence of these microorganisms was also detected in fruit and vegetable produce [3,4]. Furthermore, poor hand washing and contact with infected pets are some of the contamination routes. Thus, as a consequence of the growth in consumption of products of animal origin and the integration of companion animals in households, there is an increased potential for exposure to Salmonella via the food chain [4].
When contaminated food is ingested, the pathogen attacks and invades the intestinal epithelium of the distal ileum triggering sickness that appears as acute gastroenteritis within 4 to 72 h. Fever, chills, nausea, vomiting, abdominal cramping, headache, and diarrhea are the main symptoms [1,4]. Usually, in healthy individuals, NTS is a self-limited disease resolving in a few days without medical intervention, but some patients may develop chronic sequelae such as reactive arthritis or irritable bowel syndrome [4,5]. On the other hand, in vulnerable patients (immunocompromised, very young or elderly persons) NTS infection can systematically spread to other body organs causing febrile illness [2,3,4]. Hence, NTS is a public health concern representing an economic burden for both developed and developing countries, due to costs associated with surveillance, prevention, and treatment of disease [1,6,7].
The rise in the occurrence of antimicrobial-resistant (AMR) strains in the food chain increases the risk associated with this zoonotic infectious disease minimizing treatment options and increasing human mortality [8,9]. The emergence of antimicrobial resistance in the food chain is considered a cross-sectoral problem due to: (i) the misuse and overuse of antibiotics in agricultural and livestock production, (ii) the dissemination of antimicrobial resistance genes (ARGs) among bacteria intentionally added during processing (e.g., starter cultures and probiotics), (iii) the post-contamination by the environment, after food processing, (iv) the cross-contamination with AMR bacteria colonizing other foods during industrial processing and handling by the consumer [10,11].
The selective effects of antimicrobial use accelerate the natural development of resistance mechanisms activated by bacteria, and the acquisition of ARGs can occur at any stage of the food chain facilitated by mobile genetic structures such as plasmids, integrons, and transposons, in addition to vertical transfer [11,12]. Indeed, the presence of resistance determinants in foodstuffs increases the gene pool by which pathogens can achieve and transfer ARGs to other bacteria, thus representing an indirect risk to public health [11].
Horizontal gene transfer has been repeatedly described in Salmonella, especially for tetracycline resistance genes (tet) because some of the most frequently detected, such as tetA and tetG, are located on mobile genetic elements [13]. As observed in the latest report of the European Food Safety Authority (EFSA), Italy showed a high level of resistance toward tetracyclines, confirming the alarming effects caused by the abuse of these broad-spectrum agents in both human and veterinary medicine [3,13]. In light of recent scientific issues on antimicrobial resistance, the EFSA updated technical specifications for the implementation of molecular typing methods during routine monitoring. EFSA proposal aims to reach harmonised surveillance of antimicrobial resistance in food-producing animals and derived food to ensure continuity in following up the dynamic evolution of AMR foodborne pathogens [14]. Mobile genetic elements play a pivotal role in the dissemination of antimicrobial resistance along the food chain and their study is crucial to better understand their epidemiology, apply control measures and reduce the presence of the pathogen in food [11].
In this study, we selected a group of strains isolated in the Marche Region including those serotypes mainly detected in Salmonella strains. Within this collection, we evaluated their distribution in each one of the niches considered (animal, food, environment, and human), their antimicrobial resistance, and plasmid profiles in order to obtain a general view of isolates circulating in our region. Our aim was to investigate the presence and the potential dissemination of AMR Salmonella isolates via the food chain.

2. Results

2.1. Salmonella Strains

A total of 102 AMR Salmonella strains, of serovars S. Derby (n. 20), S. Typhimurium (n. 18), MVST (n. 28), and S. Infantis (n. 36) were collected and analysed for this study. Strains of animal origin (n. 16) were from pigs (n. 5) and poultry (broiler, n. 8; pigeon, turkey, and laying hen, n. 1 each); food samples (n. 35) included meat products (pork meat, n. 20; bovine, n. 4; chicken, n. 7), and mollusks (n. 4). Environmental samples (n. 9) were swabs from food processing rooms (n. 2), slaughter rooms (n. 4), and poultry farms (n. 3) (Table 1). Human clinical Salmonella strains (n. 42) were isolated from faeces (n. 37), blood (n. 2) urine (n. 2), and other clinical samples (n. 1) (Table 1).

2.2. Antibiotic Susceptibility Profiles

All Salmonella strains analysed in this study were resistant to one or more antibiotic classes, except for one unique environmental Salmonella isolate, that was intermediate resistant to streptomycin and ciprofloxacin and sensitive to all other antibiotics tested. Nevertheless, this last strain was included in our collection in order to obtain a reasonable number of environmental strains, in light of the limited size of this niche. The supplementary Figure S1 showed the distribution of antibiotic resistance detected among strains isolated from the different niches. Independently of isolation origin and serovar, a high rate of resistance was recorded to sulfisoxazole (88 out of 102 strains, 86%) and tetracycline (83/102, 81%), followed by ampicillin (78/102, 76%), streptomycin (61/102, 60%) and nalidixic acid (38/102, 37%). Finally, 26 strains (25%) were resistant to cefotaxime and confirmed as extended-spectrum β-lactamase (ESBL)-producing Salmonella. Moreover, a high proportion of Salmonella isolates (42%; 43/102) showed intermediate sensitivity to ciprofloxacin, a 2nd generation fluoroquinolone, whereas meropenem resistant strains were not detected (Figure 1A).
As shown in Figure 1B, the majority of strains (47/102, 46%) were resistant to three or more antibiotic classes, hence they were classified as multidrug-resistant (MDR) [15], whereas the 44% of strains (45/102) were classified extensively drug-resistant (XDR) because they were resistant to at least one agent in all but two or fewer antimicrobial categories (i.e., bacterial isolates remain susceptible to only one or two categories) [15]. The remaining 9 strains showed resistance to up two antibiotics of two categories.
The resistant phenotype was not equally distributed among serovars. In S. Infantis, strains resistant to tetracycline, sulfamides, streptomycin, nalidixic acid, pefloxacin, ampicillin, and cefotaxime were the most frequently observed, while reduced sensitivity to ciprofloxacin was noticed among a relevant number of strains which were resistant to other antibiotics. Streptomycin, sulfisoxazole, and tetracycline were the most observed resistance phenotypes in S. Derby. S. Typhimurium and MVST showed similar antibiotic resistance profiles: ampicillin, sulfisoxazole, streptomycin, and tetracycline were the most diffused resistance phenotypes in both serovars, and S. Typhimurium also showed a certain proportion of strains resistant to chloramphenicol (Figure 2).

2.3. Tetracycline Resistance Genes

Among the 83 resistant strains and the three strains with intermediate sensitivity to tetracycline, a tet gene was determined in 43 strains, while the remaining 43 strains tested negative for each target. The gene most frequently detected was tetB (27/86), followed by tetA (10/86) and tetG (5/86), while tetM was found in a single strain isolated from humans and was in combination with tetB. On the other hand, tetC and tetD were not detected (Table 2).
To note, almost all determinants were heterogeneously distributed both in terms of serovars and niches. However, tetA was not found in MVST that was instead characterised by the carriage of tetB for the 97% of tetracycline-resistant strains. Further, tetG gene was detected only in S. Typhimurium strains, and all were isolated from food (Table 2).

2.4. Replicon Typing

Among the 102 strains analysed by PBRT only 12 out 30 replicons were detected (HI2, I1α, N, I2, FIB, I1γ, A/C, FIIS, X1, FIB KN, FII, X4), as described in Figure 3A.
Overall, 58 strains were untypeable because they were negative for all replicons whereas 28 strains were positive for 1 replicon, 11 for 2 replicons, and 5 for 3 replicons. FIIS was the most predominant replicon (17%), followed by FII (11%), and FIB (11%). However, we observed specific replicon distribution among strains belonging to the serovars considered in this study. Indeed, the IncX group was detected in S. Infantis and MVST, IncF in S. Typhimurium, S. Infantis, and MVST whereas IncI and IncH were detected only in S. Derby.
Furthermore, replicons IncI and IncH were detected in strains isolated from human and food samples, IncF group was the most detected in strains isolated from animal, food, and human samples whereas, among strains isolated from the environment, only the IncX group was detected (Figure 3B).
Results of the PBRT analysis allowed us to define 18 PBRT profiles (i.e., combinations of replicons). The prevalent profile included strains with the single replicon FIIS (n = 11/102), followed by I1α (n = 4/102), and FIB,FII (n = 4/102). All PBRT profiles detected in the present study comprised strains of the same serovar, except for HI2 detected in both S. Derby and MVST, and X1 detected in MVST and S. Infantis (Figure 3B). Multireplicon status (two or more replicons) was recorded in 16 strains, with a maximum of three replicons in five MVST strains. Multireplicon profiles were the following: FIB,A/C,FII (n = 1), I1α,FIB,FII (n = 1), and FIB,FIIS,FII (n = 3). Four out of these five strains having the multireplicon profile were resistant to tetracycline, three of which carried tetB gene or tetB combined with tetM.
In this study, the possible association between the Inc group and resistance phenotypes was also investigated. Results of statistical analysis (Hypothesis test–difference between two frequencies in large samples) showed significant association between IncF presence and resistance to sulfisoxazole (p < 0.00001), chloramphenicol (p < 0.0001), streptomycin (p < 0.01), ampicillin (p < 0.01) and tetracycline (p < 0.05).

3. Discussion

In this study, the characterisation of Salmonella strains belonging to the main serovars isolated from the food chain in the Marche Region (Central Italy) is reported. The decision to select S. Infantis, S. Derby, S. Typhimurium, and MVST as the target of the investigation was derived from taking into account the epidemiology of main serovars circulating at the regional level in both veterinary and human samples [16,17,18,19,20,21]. The dominance of these four serovars was consistent with that observed at the national and European levels, as described by the last reports of Entervet and EFSA/ECDC [3,22].
With the exception of S. Typhimurium which presents a global distribution [23], geographical differences emerged comparing the serovars predominant in Europe with those in the USA, with the prevalence of S. Enteritidis and S. Newport for the latter [23,24].
All serovars considered in the present work are commonly found along the food chain and they are able to cause infections in humans [23]. S. Typhimurium and its monophasic variant (MVST) are associated with pig and pork meat [3]. In food-processing environments, these pathogens can spread throughout processing lines and, thus, reach utensils, surfaces, and hands of employees [25]. Indeed, the prevalence of S. Typhimurium and its monophasic variant is similar in both farms and slaughterhouses, and strains isolated from swine and humans show important correlations in terms of molecular profiles [23,26]. S. Derby is continuously detected in pig, slaughter, and pork meat [3], and several studies demonstrated correlations between strains isolated from pigs and those of human origin [27,28]. S. Infantis is reported as the most frequent poultry-adapted S. enterica serovar with an increasing occurrence in broiler flocks, derived meat, and breeding hens [29,30].
From a health perspective, these findings are remarkable because the spread along the food chain of serovars with the ability to cause infections in humans represents a great concern. Indeed, Salmonella is the second pathogen responsible for food-transmitted diseases and is an important cause of foodborne outbreaks in the EU [3].
Over recent years, the risk associated with the increasing incidence of these serovars in humans and animals has been complicated by the spread of MDR clones in several European countries, including Italy [31,32]. The overuse of antimicrobial agents in therapy and prophylaxis of human and animal infections, as well as growth-promoting agents in food animal production, favored the emergence of Salmonella strains resistant to several classes of antibiotics, including those used as the primary choice for clinical treatment [33]. In light of this, we presented new and updated data concerning not only the occurrence of the most prevalent serovars detected at the regional level but also their molecular features in terms of antibiotic resistance and plasmid profiles. We found a heterogeneous distribution of phenotypic resistance among the serovars investigated, confirming also the typical multi-resistance pattern frequently determined in Salmonella strains circulating in Europe [34].
Tetracyclines, which are broad-spectrum drugs widely used in human and veterinary medicine, represent one of the main agents toward which Salmonella developed a high level of resistance [35]. As reported by the latest ESVAC (European Surveillance of Veterinary Antimicrobial Consumption) report, of the overall antimicrobials used in the 31 countries in 2020, the largest amounts were for penicillins (31.1%), tetracyclines (26.7%), and sulfonamides (9.9%) [36]. In our study the highest resistance rate was determined toward sulfisoxazole, followed by tetracycline, both classified as highly important antibiotics for human medicine [37]. Thus, the responsible use of them is strongly recommended in order to keep the associated risk as low as possible [38].
This study demonstrated wide dissemination of tetracycline resistance in Salmonella strains (80%) along with the considered food chain settings. This was in accordance with the last report released by EFSA where a rate of tetracycline resistance higher than the European average was described for Italy [34]. Among all tetracycline-resistant strains of our collection, 49% harboured one or more tet genes (tetA, tetB, tetC, tetD, tetG, tetM), matching with other studies carried out both in Italy and in Europe [39,40,41]. The fact that only 49% of strains resistant to tetracycline were positive for at least one tet gene is not surprising because this resistance could be due to different genes or other mechanisms such as mutations within the ribosomal binding site, activity of efflux pumps or enzymatic inactivation of tetracycline drugs [42]. In agreement with other authors, the genes most frequently detected in the present work were tetA and tetB belonging to Group-I and associated with an efflux pump mechanism [43,44,45,46]. On the contrary, all strains of our collection were negative for tetC and tetD. This result is not uncommon and could be due to the low ability of those genes to confer resistance to tetracycline [46], leading to their infrequent detection. The presence of these genes in strains isolated from animals increases the risk associated with circulating Salmonella strains in livestock for many reasons. Firstly, animals can transfer these strains to humans when farmers come into close contact with them. Secondly, animals can release strains through faecal material contributing to the spread of ARGs within livestock, and cross-contamination events, due to low hand hygiene compliance which can occur during processing.
Remarkably, the localization of many ARGs on mobile genetic elements (plasmids, integrons, and transposons) makes them easily transferred to both other bacteria and the environment [47]. This is the case of tetA and tetB which are the most frequently detected genes in our collection, confirming their increased ability to spread.
Hence, screening programmes supported by molecular typing methods are very useful for the epidemiological tracing of serovar distribution in different sources along the food chain, and also for the prompt identification of potential risks for the health of farmers, food handlers, and consumers. For this reason, all strains were further characterised by PBRT in order to understand the distribution of plasmid-related antimicrobial resistance determinants based upon replicon types.
It is known that a variety of plasmid families are frequently found in Enterobacterales promoting the rapid and consistent dissemination of ARGs [48]. The most common Inc replicon types found in our collection were IncFIIS, followed by IncFII and IncFIB. The dominance of IncF plasmids in AMR Enterobacterales isolated from humans and animals has been widely assessed [48,49]. It was also demonstrated that IncF plasmids carry multireplicon patterns where one replicon is strongly conserved while the others are free to diverge. So, the selective pressure imposed leads plasmids to duplication and dissemination [49]. Furthermore, the low copy number IncF plasmids contain the ADP-ribosylating toxin, SpvB causing the systemic virulence typical of some serovars such as S. Derby and S. Typhimurium [50]. For all of these reasons, the implementation of molecular investigation in surveillance programmes achieves more and more relevance.
Besides the described dominance of IncF, previous studies carried out in Italy recorded the occurrence of different plasmid replicons. Dionisi and colleagues [32] characterised S. Infantis isolated from different sources, between 2005 and 2011, identifying IncHI1 as the dominant replicon. Instead, Franco and colleagues [31] investigated S. Infantis isolates from different broiler chicken flocks detecting IncP replicon in all of them. Interestingly, Di Cesare and colleagues [51] reported a large variety of Inc-plasmids among isolates from animals and foodstuffs, highlighting the diversity of the Salmonella serovars. To note, IncHI2 and IncFIIS were prevalent and detected only in specific serovars suggesting that their distribution could be serovar-dependent [51]. This issue was found in accordance with that observed in our study where IncH and IncI were found to be associated only with S. Derby while IncX was detected only in MVST and S. Infantis strains originated from food and human samples, suggesting their potential transmission along the food chain.
A large part of strains was untypeable by PBRT, and what could be a limitation for the study actually highlights the need of monitoring circulating strains continuously, in order to follow the dynamic evolution of Salmonella. This foodborne pathogen, as well as other bacteria, has a tendency to modify its molecular elements to obtain advantageous adaptability resulting in the escape of current assays.
It is clear that a better knowledge of molecular aspects in terms of resistance determinants and plasmid content can be helpful to understand how resistant bacteria spread within food settings.

4. Materials and Methods

4.1. Study Design and Selection of Strains

This study considered Salmonella strains isolated from different samples collected in the Marche Region, Italy, between 2015 and 2021, in the framework of the official controls provided by the Regulation (EC) No 2073/2005 on microbiological food safety criteria [52] the National Poultry monitoring plan [53,54] and during self-monitoring controls both in food [52] and veterinary sectors [54].
Salmonella strains were collected from microbiological analysis performed as part of these controls and serotyped at the Regional Reference Centre for Enteric Pathogens of the Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche, section of Tolentino (Italy).
Only AMR strains of the main circulating serovars were selected including S. Derby (n = 20/102; 20%), S. Infantis (n = 36/102; 35%), S. Typhimurium (n = 18/102; 18%), and MVST (n = 28/102; 27%). The dominance of these serovars was derived from epidemiological information about the main serovars circulating in both veterinary and human samples [3,21]. Among them, we selected MDR strains to perform their further characterisation in terms of resistance to tetracycline agent, carriage of tet genes, and plasmid profiles.
Isolation sources included different points of the food chain, from farm and veterinary environments to food and food processing plants. Animal samples were obtained mainly from pigs and poultry (faeces, dust, and boot swabs collected on farms, viscera collected during necropsy) while food samples included meat and fish products. Environmental samples were obtained by collecting swabs from food processing rooms, slaughter rooms, and poultry farms. Finally, human Salmonella strains were isolated from people with gastrointestinal symptoms, some of them hospitalized. These strains were sent to the Regional Reference Centre for Enteric Pathogens from the Regional hospitals’ analysis laboratories participating in Enter-Net surveillance for Marche Region. Strain origin and serotypes were reported in Table 1.

4.2. Serotyping Analysis and Antibiotic Susceptibility Testing

All Salmonella isolates from either veterinary, food or human samples were serotyped according to ISO/TR 6579-3:2014 [55].
Antimicrobial susceptibility of the Salmonella strains was determined by the disk diffusion method, according to the Clinical and Laboratory Standards Institute guidelines (CLSI, 2021) toward the following antibiotic agents: ampicillin (AMP, 10 μg), cefotaxime (CTX, 30 μg), ceftazidime (CAZ, 30 μg), amoxicillin+clavulanic acid (AMC, 30 μg), cefoxitin (FOX, 30 µg), meropenem (MEM, 10 μg), tetracycline (TE, 30 μg), chloramphenicol (C, 30 μg), ciprofloxacin (CIP, 5 μg), nalidixic acid (NA, 30 μg), pefloxacin (PEF, 5 μg), gentamicin (CN, 10 μg), streptomycin (S, 10 μg), trimethoprim-sulfamethoxazole (SXT, 23.75/1.25 μg), sulfisoxazole (ST, 300 μg), trimethoprim (TMP, 5 μg). Escherichia coli ATCC 25922 was used as a control strain.
ESBL-producing Salmonella strains were confirmed by the double-disk synergy test performed by positioning a disk of amoxicillin+clavulanic acid 30 µg between a disk of cefotaxime 30 μg and a disk of ceftazidime 30 μg [56]. The CLSI interpretive criteria for disk diffusion susceptibility testing of Salmonella were used [57].

4.3. Bacterial DNA Extraction and Plasmid Typing

Bacterial DNA was obtained by the boiling lysis method, incubating the isolated colonies in distilled water for 10 min at 100 °C. The samples were then centrifuged at 15,000× g for 5 min and the supernatants were used for the following reactions.
All strains were typed by PCR-based replicon typing (PBRT) using the PBRT kit 2.0 (Diatheva, Fano, Italy) in order to identify plasmid replicons. This PBRT assay consists of eight multiplex PCRs and allows the detection of 30 replicons of the main plasmids in Enterobacterales.
All PCR reactions were carried out in accordance with the manufacturer’s instructions, including positive controls. The amplicons were detected through capillary electrophoresis on the AATI Fragment Analyzer (Agilent, Santa Clara, CA, USA) using the dsDNA 906 Reagent kit (Advanced Analytical, Ankeny, IA, USA). This amplicon analysis allows the combination of two multiplex PCRs in the same lane, resolving up to eight peaks, as previously published [58]. The positive peaks were successively analysed using the tool “PBRT plugin” [58] developed in cooperation with the Advanced Analytical Company that allows automatic peak calling and the recording of positive replicons.

4.4. PCR screening of Tetracycline Resistance Genes

Salmonella strains with tetracycline-resistant (n. 83) and intermediate (n. 3) phenotypes were investigated to detect the presence of tetA, tetB, tetC, tetD, tetG, and tetM genes by PCR. All PCR reactions were carried out following protocols indicated by the European Reference Laboratory for Antimicrobial Resistance (EURL-AR, Technical University of Denmark, National Food Institute) [59] (Table 3).
Positive control strains for the above-mentioned tet genes were also provided by the EURL-AR (Table 4).
The PCR products were separated by electrophoresis on a 1.5% (w/v) agarose/midori green advance color gel (Resnova, Rome, Italy) and finally recorded using UV transillumination. A 100 bp DNA ladder (GeneRuler 100 bp Plus, ThermoFisher Scientific, Waltham, US) was included in all agarose gels as a molecular weight standard.

4.5. Statistical Analysis

The association between the presence of the Inc plasmid group and the resistance phenotype was analyzed by the Hypothesis test–difference between two frequencies in large samples. A p-value < 0.05 was considered significant.

5. Conclusions

In conclusion, this study shows that a heterogeneous Salmonella serovars population colonizes the food chain with the ability to reach consumers and cause serious illnesses. Isolates analysed here were characterised by a high rate of resistance to a wide panel of antibiotics, and particular attention was focused on tetracyclines considering the extensive use of this agent in veterinary medicine. The presence of MDR strains carrying genetic determinants on mobile genetic elements is a matter of concern for the spread of resistance in food settings.
In this context, the monitoring of different serovars along the food chain and a better knowledge of them from a molecular point of view are essential to managing risks associated with consumer health.
Greater coordination across all sectors of the food chain is needed to fight antibiotic resistance, and the implementation of molecular typing methods within routinary screening programmes can become an important tool of the One Health preventive approach.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/antibiotics11060725/s1, Figure S1: AMR profiles of Salmonella strains investigated in this study according to the isolation source. AMP, ampicillin; CTX, cefotaxime; CAZ, ceftazidime; AMC, amoxicillin+clavulanic acid; FOX, cefoxitin; MEM, meropenem; TE, tetracycline; C, chloramphenicol; CIP, ciprofloxacin; NA, nalidixic acid; PEF, pefloxacin; CN, gentamicin; S, streptomycin; SXT, trimethoprim-sulfamethoxazole; ST, sulfisoxazole; TMP, trimethoprim.

Author Contributions

Conceptualization, F.A., G.F.S., D.B., G.A. and G.B. (Giorgio Brandi); methodology, I.R., D.B., F.A. and M.N.; formal analysis, D.B., F.A., G.F.S. and G.A.; investigation, I.R., D.B., M.N., G.B. (Giulia Baldelli); data curation, G.A., G.B. (Giorgio Brandi), G.F.S.; writing—original draft preparation, D.B., and I.R.; writing—review and editing, I.R., D.B., F.A., G.B. (Giorgio Brandi), G.F.S. and G.A.; supervision, G.B. (Giorgio Brandi). All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially funded with internal funds from the Department of Biomolecular Sciences, University of Urbino Carlo Bo (Funds dedicated to Research Projects about Food Safety, Delibera del Consiglio del DISB n. 30/2020, 5 February 2020).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are present within the article.

Acknowledgments

The authors are grateful to the EURL-AR, Technical University of Denmark, National Food Institute, Lyngby, Denmark, for providing bacterial strains used as positive controls in PCR targeting tet genes. The authors would also like to thank M. Carletti for her help with the statistical analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gal-Mor, O. Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae. Clin. Microbiol. Rev. 2018, 32, e00088-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Haselbeck, A.H.; Panzner, U.; Im, J.; Baker, S.; Meyer, C.G.; Marks, F. Current perspectives on invasive nontyphoidal Salmonella disease. Curr. Opin. Infect. Dis. 2017, 30, 498–503. [Google Scholar] [CrossRef] [PubMed]
  3. European Food Safety Authority; European Centre for Disease Prevention and Control. The European Union One Health 2019 Zoonoses Report. EFSA J. 2021, 19, e06406. [Google Scholar]
  4. Ehuwa, O.; Jaiswal, A.K.; Jaiswal, S. Salmonella, Food Safety and Food Handling Practices. Foods 2021, 10, 907. [Google Scholar] [CrossRef] [PubMed]
  5. Keithlin, J.; Sargeant, J.M.; Thomas, M.K.; Fazil, A. Systematic review and meta-analysis of the proportion of non-typhoidal Salmonella cases that develop chronic sequelae. Epidemiol. Infect. 2015, 143, 1333–1351. [Google Scholar] [CrossRef] [Green Version]
  6. Ao, T.T.; Feasey, N.A.; Gordon, M.A.; Keddy, K.H.; Angulo, F.J.; Crump, J.A. Global burden of invasive nontyphoidal Salmonella disease, 2010. Emerg. Infect. Dis. 2015, 21, 941–949. [Google Scholar] [CrossRef] [Green Version]
  7. Majowicz, S.E.; Musto, J.; Scallan, E.; Angulo, F.J.; Kirk, M.; O’Brien, S.J.; International Collaboration on Enteric Disease “Burden of Illness” Studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. 2010, 50, 882–889. [Google Scholar] [CrossRef] [Green Version]
  8. V.T. Nair, D.; Venkitanarayanan, K.; Kollanoor Johny, A. Antibiotic-Resistant Salmonella in the Food Supply and the Potential Role of Antibiotic Alternatives for Control. Foods 2018, 7, 167. [Google Scholar] [CrossRef] [Green Version]
  9. Wang, X.; Biswas, S.; Paudyal, N.; Pan, H.; Li, X.; Fang, W.; Yue, M. Antibiotic Resistance in Salmonella Typhimurium Isolates Recovered from the Food Chain Through National Antimicrobial Resistance Monitoring System Between 1996 and 2016. Front. Microbiol. 2019, 10, 985. [Google Scholar] [CrossRef] [Green Version]
  10. Founou, L.L.; Founou, R.C.; Essack, S.Y. Antibiotic Resistance in the Food Chain: A Developing Country-Perspective. Front. Microbiol. 2016, 7, 1881. [Google Scholar] [CrossRef]
  11. Verraes, C.; Van Boxstael, S.; Van Meervenne, E.; Van Coillie, E.; Butaye, P.; Catry, B.; de Schaetzen, M.-A.; Van Huffel, X.; Imberechts, H.; Dierick, K.; et al. Antimicrobial resistance in the food chain: A review. Int. J. Environ. Res. Public Health 2013, 10, 2643–2669. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Bennani, H.; Mateus, A.; Mays, N.; Eastmure, E.; Stärk, K.D.C.; Häsler, B. Overview of Evidence of Antimicrobial Use and Antimicrobial Resistance in the Food Chain. Antibiotics 2020, 9, 49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Pezzella, C.; Ricci, A.; DiGiannatale, E.; Luzzi, I.; Carattoli, A. Tetracycline and streptomycin resistance genes, transposons, and plasmids in Salmonella enterica isolates from animals in Italy. Antimicrob. Agents Chemother. 2004, 48, 903–908. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. European Food Safety Authority (EFSA); Aerts, M.; Battisti, A.; Hendriksen, R.; Kempf, I.; Teale, C.; Tenhagen, B.; Veldman, K.; Wasyl, D.; Guerra, B.; et al. A Technical specifications on harmonised monitoring of antimicrobial resistance in zoonotic and indicator bacteria from food-producing animals and food. EFSA J. 2019, 17, e05709. [Google Scholar]
  15. Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Monnet, D.L. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef] [Green Version]
  16. Staffolani, M.; Medici, L.; Napoleoni, M.; Fisichella, S. Data on isolates of enteric bacteria from human clinical cases, animals, food and environment samples, in the year 2015 in Marche Region (Italy). Sanità Pubblica Vet. 2016, 95. Available online: http://www.spvet.it/archivio/numero-95/626.html (accessed on 9 May 2022).
  17. Staffolani, M.; Medici, L.; Napoleoni, M.; Fisichella, S. Data on isolates of enteric bacteria from human clinical cases, animals, food and environment samples, in the year 2016 in Marche Region (Italy). Sanità Pubblica Vet. 2017, 101. Available online: http://www.spvet.it/archivio/numero-101/660.html (accessed on 9 May 2022).
  18. Napoleoni, M.; Medici, L.; Staffolani, M.; Fisichella, S. Data on isolates of enteric bacteria from human clinical cases, animals, food and environment samples, in the year 2017 in Marche Region (Italy). Sanità Pubblica Vet. 2018, 110. Available online: http://www.spvet.it/archivio/numero-110/688.html (accessed on 9 May 2022).
  19. Napoleoni, M.; Medici, L.; Staffolani, M.; Fisichella, S. Data on isolates of enteric bacteria from human clinical cases, animals, food and environment samples in the year 2018 in Marche Region (Italy). Sanità Pubblica Vet. 2019, 114. Available online: http://spvet.it/archivio/numero-114/697.html (accessed on 9 May 2022).
  20. Napoleoni, M.; Staffolani, M.; Pazzaglia, I.; Fisichella, S. Data on isolates of enteric bacteria from human clinical cases, animals, food and environment samples in the year 2019 in Marche Region (Italy). Sanità Pubblica Vet. 2020, 118. Available online: http://spvet.it/archivio/numero-118/705.html (accessed on 9 May 2022).
  21. Napoleoni, M.; Silenzi, V.; Staffolani, M.; Guidi, F.; Blasi, G.; Fisichella, S.; Rocchegiani, E. Data on isolates of enteric bacteria from human clinical cases, animals, food and environment samples in the year 2020 in Marche Region (Italy). Sanità Pubblica Vet. 2021, 125. Available online: http://www.spvet.it/archivio/numero-125/718.html (accessed on 9 May 2022).
  22. Leati, M.; Cibin, V.; Mancin, M.; Pestelli, P.; Barco, L. Enter-Vet Report Dati 2019; Centro di Referenza Nazionale per le Salmonellosi; Istituto Zooprofilattico Sperimentale delle Venezie: Legnaro (PD), Italy, 2022; pp. 1–38. [Google Scholar]
  23. Ferrari, R.G.; Rosario, D.K.A.; Cunha-Neto, A.; Mano, S.B.; Figueiredo, E.E.S.; Conte-Junior, C.A. Worldwide Epidemiology of Salmonella Serovars in Animal-Based Foods: A Meta-analysis. Appl. Environ. Microbiol. 2019, 85, e00591-19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Crim, S.M.; Iwamoto, M.; Huang, J.Y.; Griffin, P.M.; Gilliss, D.; Cronquist, A.B.; Cartter, M.; Tobin-D’Angelo, M.; Blythe, D.; Smith, K.; et al. Incidence and Trends of Infection with Pathogens Transmitted Commonly Through Food—Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006–2013. MMWR Morb. Mortal. Wkly. Rep. 2020, 63, 328–332. [Google Scholar]
  25. Gomes-Neves, E.; Antunes, P.; Tavares, A.; Themudo, P.; Cardoso, M.F.; Gärtner, F.; Costa, J.M.; Peixe, L. Salmonella cross-contamination in swine abattoirs in Portugal: Carcasses, meat and meat handlers. Int. J. Food Microbiol. 2012, 157, 82–87. [Google Scholar] [CrossRef] [PubMed]
  26. Ferrari, R.G.; Panzenhagen, P.H.N.; Conte-Junior, C.A. Phenotypic and Genotypic Eligible Methods for Salmonella Typhimurium Source Tracking. Front. Microbiol. 2017, 8, 2587. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Wu, C.; Yan, M.; Liu, L.; Lai, J.; Chan, E.W.; Chen, S. Comparative characterization of nontyphoidal Salmonella isolated from humans and food animals in China, 2003–2011. Heliyon 2018, 4, e00613. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Kerouanton, A.; Rose, V.; Weill, F.X.; Granier, S.A.; Denis, M. Genetic diversity and antimicrobial resistance profiles of Salmonella enterica serotype derby isolated from pigs, pork, and humans in France. Foodborne Pathog. Dis. 2013, 10, 977–984. [Google Scholar] [CrossRef] [Green Version]
  29. Alba, P.; Leekitcharoenphon, P.; Carfora, V.; Amoruso, R.; Cordaro, G.; Di Matteo, P.; Engage-Eurl-Ar Network Study Group. Molecular epidemiology of Salmonella Infantis in Europe: Insights into the success of the bacterial host and its parasitic pESI-like megaplasmid. Microb. Genom. 2020, 6, e000365. [Google Scholar] [CrossRef]
  30. Mughini-Gras, L.; van Hoek, A.H.; Cuperus, T.; Dam-Deisz, C.; van Overbeek, W.; van den Beld, M.; Wit, B.; Rapallini, M.; Wullings, B.; Franz, E.; et al. Prevalence, risk factors and genetic traits of Salmonella Infantis in Dutch broiler flocks. Vet Microbiol. 2021, 258, 109120. [Google Scholar] [CrossRef]
  31. Franco, A.; Leekitcharoenphon, P.; Feltrin, F.; Alba, P.; Cordaro, G.; Iurescia, M.; Battisti, A. Emergence of a Clonal Lineage of Multidrug-Resistant ESBL-Producing Salmonella Infantis Transmitted from Broilers and Broiler Meat to Humans in Italy between 2011 and 2014. PLoS ONE 2015, 10, e0144802. [Google Scholar] [CrossRef] [Green Version]
  32. Dionisi, A.M.; Lucarelli, C.; Benedetti, I.; Owczarek, S.; Luzzi, I. Molecular characterisation of multidrug-resistant Salmonella enterica serotype Infantis from humans, animals and the environment in Italy. Int. J. Antimicrob. Agents 2011, 38, 384–389. [Google Scholar] [CrossRef] [PubMed]
  33. Elnekave, E.; Hong, S.L.; Lim, S.; Johnson, T.J.; Perez, A.; Alvarez, J. Comparing serotyping with whole-genome sequencing for subtyping of non-typhoidal Salmonella enterica: A large-scale analysis of 37 serotypes with a public health impact in the USA. Microb. Genom. 2020, 6, mgen000425. [Google Scholar] [CrossRef] [PubMed]
  34. European Food Safety Authority; European Centre for Disease Prevention and Control. The European Union Summary Report on Antimicrobial Resistance in Zoonotic and Indicator Bacteria from Humans, Animals and Food in 2018/2019. EFSA J. 2021, 19, e06490. [Google Scholar]
  35. Frech, G.; Schwarz, S. Molecular analysis of tetracycline resistance in Salmonella enterica subsp. enterica serovars Typhimurium, enteritidis, Dublin, Choleraesuis, Hadar and Saintpaul: Construction and application of specific gene probes. J. Appl. Microbiol. 2000, 89, 633–641. [Google Scholar] [CrossRef]
  36. European Medicines Agency; European Surveillance of Veterinary Antimicrobial Consumption. Sales of Veterinary Antimicrobial Agents in 31 European Countries in 2019 and 2020; Eleventh ESVAC Report EMA/58183/2021; 2021; Available online: https://www.ema.europa.eu/en/documents/report/sales-veterinary-antimicrobial-agents-31-european-countries-2019-2020-trends-2010-2020-eleventh_en.pdf (accessed on 9 May 2022).
  37. WHO. Critically Important Antimicrobials for Human Medicine, 6th Revision. 2019. Available online: https://www.who.int/foodsafety/publications/antimicrobials-sixth/en/https://www.who.int/publications/i/item/9789241515528 (accessed on 9 May 2022).
  38. European Union (EU). Commission Notice—Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04). Off. J. Eur. Union 2015, 58, 7–26. Available online: https://ec.europa.eu/health/system/files/2016-11/2015_prudent_use_guidelines_en_0.pdf (accessed on 9 May 2022).
  39. Gargano, V.; Sciortino, S.; Gambino, D.; Costa, A.; Agozzino, V.; Reale, S.; Vicari, D. Antibiotic Susceptibility Profile and Tetracycline Resistance Genes Detection in Salmonella spp. Strains Isolated from Animals and Food. Antibiotics 2021, 10, 809. [Google Scholar] [CrossRef]
  40. Bacci, C.; Lanzoni, E.; Vismarra, A.; Alpigiani, I.; Nuvoloni, R.; Bonardi, S.; Brindani, F. Antibiotic resistance and resistance genes in Salmonella enterica isolated from pork meat and pig carcasses in Northern Italy. Large Animal. Rev. 2014, 20, 201–207. [Google Scholar]
  41. García-Soto, S.; Abdel-Glil, M.Y.; Tomaso, H.; Linde, J.; Methner, U. Emergence of Multidrug-Resistant Salmonella enterica Subspecies enterica Serovar Infantis of Multilocus Sequence Type 2283 in German Broiler Farms. Front. Microbiol. 2020, 11, 1741. [Google Scholar] [CrossRef]
  42. Grossman, T.H. Tetracycline Antibiotics and Resistance. Cold Spring Harb. Perspect. Med. 2016, 6, a025387. [Google Scholar] [CrossRef] [Green Version]
  43. Lauteri, C.; Maggio, F.; Serio, A.; Festino, A.R.; Paparella, A.; Vergara, A. Overcoming Multidrug Resistance in Salmonella spp. Isolates Obtained From the Swine Food Chain by Using Essential Oils: An in vitro Study. Front. Microbiol. 2022, 12, 808286. [Google Scholar] [CrossRef]
  44. Peruzy, M.F.; Capuano, F.; Proroga, Y.T.R.; Cristiano, D.; Carullo, M.R.; Murru, N. Antimicrobial Susceptibility Testing for Salmonella Serovars Isolated from Food Samples: Five-Year Monitoring (2015–2019). Antibiotics 2020, 9, 365. [Google Scholar] [CrossRef]
  45. Pavelquesi, S.L.S.; de Oliveira Ferreira, A.C.A.; Rodrigues, A.R.; de Souza Silva, C.M.; Orsi, D.C.; da Silva, I.C.R. Presence of Tetracycline and Sulfonamide Resistance Genes in Salmonella spp.: Literature Review. Antibiotics 2021, 10, 1314. [Google Scholar] [CrossRef] [PubMed]
  46. Camarda, A.; Pugliese, N.; Pupillo, A.; Oliva, M.; Circella, E.; Dionisi, A.M.; Ricci, A.; Legretto, M.; Caroli, A.; Pazzani, C. Resistance genes, phage types and pulsed field gel electrophoresis pulsotypes in Salmonella enterica strains from laying hen farms in southern Italy. Int. J. Environ. Res. Public Health 2013, 10, 3347–3362. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Tawyabur, M.; Islam, M.; Sobur, M.; Hossain, M.; Mahmud, M.; Paul, S.; Rahman, M. Isolation and Characterization of Multidrug-Resistant Escherichia coli and Salmonella spp. from Healthy and Diseased Turkeys. Antibiotics 2020, 9, 770. [Google Scholar] [CrossRef] [PubMed]
  48. Carattoli, A. Plasmids in Gram negatives: Molecular typing of resistance plasmids. Int. J. Med. Microbiol. 2011, 301, 654–658. [Google Scholar] [CrossRef] [PubMed]
  49. Carattoli, A. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 2009, 53, 2227–2238. [Google Scholar] [CrossRef] [Green Version]
  50. Oluwadare, M.; Lee, M.D.; Grim, C.J.; Lipp, E.K.; Cheng, Y.; Maurer, J.J. The Role of the Salmonella spvB IncF Plasmid and Its Resident Entry Exclusion Gene traS on Plasmid Exclusion. Front. Microbiol. 2020, 11, 949. [Google Scholar] [CrossRef]
  51. Di Cesare, A.; Losasso, C.; Barco, L.; Eckert, E.M.; Conficoni, D.; Sarasini, G.; Corno, G.; Ricci, A. Diverse distribution of Toxin-Antitoxin II systems in Salmonella enterica serovars. Sci. Rep. 2016, 6, 28759. [Google Scholar] [CrossRef] [Green Version]
  52. European Union. Commission Regulation (EC) No 2073/2005 of 15 November 2005 on Microbiological Criteria for Foodstuffs. Off. J. Eur. Union 2005, 50, 1–26. Available online: https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32005R2073 (accessed on 9 May 2022).
  53. ISO 6579-1:2017/A1:2020; Microbiology of the Food Chain—Horizontal Method for the Detection, Enumeration and Serotyping of Salmonella—Part 1: Detection of Salmonella spp.—Amendment 1 Broader Range of Incubation Temperatures, Amendment to the Status of Annex D, and Correction of the Composition. International Organization for Standardization: Geneva, Switzerland, 2020.
  54. Italian Ministry of Health. National Control Plan for Salmonellosis in Poultry 2019–2021 (Piano Nazionale di Controllo delle Salmonellosi negli Avicoli 2019–2021). Directorate General for Animal Health and Veterinary Medicines of the Italian Ministry of Health. 2018. Available online: https://www.salute.gov.it/imgs/C_17_pubblicazioni_2849_allegato.pdf (accessed on 9 May 2022).
  55. ISO/TR 6579-3:2014; Microbiology of the Food Chain—Horizontal Method for the Detection, Enumeration and Serotyping of Salmonella—Part 3: Guidelines for Serotyping of Salmonella spp. International Organization for Standardization: Geneva, Switzerland, 2014.
  56. Jarlier, V.; Nicolas, M.H.; Fournier, G.; Philippon, A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in enterobacteriaceae: Hospital prevalence and susceptibility patterns. Clin. Infect. Dis. 1988, 10, 867–878. [Google Scholar] [CrossRef]
  57. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 32nd ed.; CLSI Supplement M100; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2022. [Google Scholar]
  58. Barbadoro, P.; Bencardino, D.; Carloni, E.; Omiccioli, E.; Ponzio, E.; Micheletti, R.; Andreoni, F. Carriage of carbapenem-resistant enterobacterales in adult patients admitted to a university hospital in italy. Antibiotics 2021, 10, 61. [Google Scholar] [CrossRef]
  59. European Reference Laboratory for Antimicrobial Resistance (EURL-AR, Technical University of Denmark, National Food Institute). List of Primers for Detection of Antimicrobial Resistance Genes. Available online: https://www.eurl-ar.eu/CustomerData/Files/Folders/25-resourcer/459_primerliste-til-web-07-11-2018.pdf (accessed on 9 May 2022).
  60. Sengeløv, G.; Agersø, Y.; Halling-Sørensen, B.; Baloda, S.B.; Andersen, J.S.; Jensen, L.B. Bacterial antibiotic resistance levels in Danish farmland as a result of treatment with pig manure slurry. Environ. Int. 2003, 28, 587–595. [Google Scholar] [CrossRef]
  61. Miranda, C.D.; Kehrenberg, C.; Ulep, C.; Schwarz, S.; Roberts, M.C. Diversity of tetracycline resistance genes in bacteria from Chilean salmon farms. Antimicrob. Agents Chemother. 2003, 47, 883–888. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Agersø, Y.; Sandvang, D. Class 1 integrons and tetracycline resistance genes in Alcaligenes, Arthrobacter, and Pseudomonas spp. isolated from pigsties and manured soil. Appl. Environ. Microbiol. 2005, 71, 7941–7947. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Resistance rate of Salmonella strains analysed in this study. (A) Strains were resistant to one or more antibiotic classes, and the major resistance was detected against sulfisoxazole and tetracycline. R: resistant (black), and I: intermediate (grey) resistant strains. AMP, ampicillin; CTX, cefotaxime; CAZ, ceftazidime; AMC, amoxicillin+clavulanic acid; FOX, cefoxitin; TE, tetracycline; C, chloramphenicol; CIP, ciprofloxacin; NA, nalidixic acid; PEF, pefloxacin; CN, gentamicin; S, streptomycin; SXT, trimethoprim-sulfamethoxazole; ST, sulfisoxazole; TMP, trimethoprim. (B) Distribution of Multi-and Extensively Drug-Resistant Salmonella strains. The major part of strains were resistant to three or more antibiotic classes (multidrug-resistant; MDR) whereas 44% were resistant to at least one agent in all but two or fewer antimicrobial categories (extensively drug-resistant; XDR) (B).
Figure 1. Resistance rate of Salmonella strains analysed in this study. (A) Strains were resistant to one or more antibiotic classes, and the major resistance was detected against sulfisoxazole and tetracycline. R: resistant (black), and I: intermediate (grey) resistant strains. AMP, ampicillin; CTX, cefotaxime; CAZ, ceftazidime; AMC, amoxicillin+clavulanic acid; FOX, cefoxitin; TE, tetracycline; C, chloramphenicol; CIP, ciprofloxacin; NA, nalidixic acid; PEF, pefloxacin; CN, gentamicin; S, streptomycin; SXT, trimethoprim-sulfamethoxazole; ST, sulfisoxazole; TMP, trimethoprim. (B) Distribution of Multi-and Extensively Drug-Resistant Salmonella strains. The major part of strains were resistant to three or more antibiotic classes (multidrug-resistant; MDR) whereas 44% were resistant to at least one agent in all but two or fewer antimicrobial categories (extensively drug-resistant; XDR) (B).
Antibiotics 11 00725 g001
Figure 2. AMR profile of Salmonella strains investigated in this study, according to serovar. R: resistant (black), and I: intermediate (grey) strains. MVST: monophasic variant of S. Typhimurium. AMP, ampicillin; CTX, cefotaxime; CAZ, ceftazidime; AMC, amoxicillin+clavulanic acid; FOX, cefoxitin; MEM, meropenem; TE, tetracycline; C, chloramphenicol; CIP, ciprofloxacin; NA, nalidixic acid; PEF, pefloxacin; CN, gentamicin; S, streptomycin; SXT, trimethoprim-sulfamethoxazole; ST, sulfisoxazole; TMP, trimethoprim.
Figure 2. AMR profile of Salmonella strains investigated in this study, according to serovar. R: resistant (black), and I: intermediate (grey) strains. MVST: monophasic variant of S. Typhimurium. AMP, ampicillin; CTX, cefotaxime; CAZ, ceftazidime; AMC, amoxicillin+clavulanic acid; FOX, cefoxitin; MEM, meropenem; TE, tetracycline; C, chloramphenicol; CIP, ciprofloxacin; NA, nalidixic acid; PEF, pefloxacin; CN, gentamicin; S, streptomycin; SXT, trimethoprim-sulfamethoxazole; ST, sulfisoxazole; TMP, trimethoprim.
Antibiotics 11 00725 g002
Figure 3. Replicons detected by PBRT and distribution of replicon patterns among Salmonella serovars isolated from different sources. (A) Replicons detected by PBRT. (B) Replicon patterns and distribution among the serovars of Salmonella strains isolated from different sources. MVST: monophasic variant of S. Typhimurium.
Figure 3. Replicons detected by PBRT and distribution of replicon patterns among Salmonella serovars isolated from different sources. (A) Replicons detected by PBRT. (B) Replicon patterns and distribution among the serovars of Salmonella strains isolated from different sources. MVST: monophasic variant of S. Typhimurium.
Antibiotics 11 00725 g003
Table 1. Source and serotypes of Salmonella strains.
Table 1. Source and serotypes of Salmonella strains.
SourceSerovarsStrain n.
AnimalsS. Infantis8
S. Derby1
S. Typhimurium1
MVST6
EnvironmentS. Infantis5
S. Derby1
S. Typhimurium0
MVST3
FoodsS. Infantis11
S. Derby8
S. Typhimurium7
MVST9
HumansS. Infantis12
S. Derby10
S. Typhimurium10
MVST10
Total 102
Table 2. tet genes detected in tetracycline-resistant and intermediate strains, and serovars.
Table 2. tet genes detected in tetracycline-resistant and intermediate strains, and serovars.
tet GenesResistant StrainsIntermediate Strains
tetA10
2 S. Derby, 7 S. Infantis, 1 S. Typhimurium
0
tetB27
1 S. Derby, 24 MVST, 2 S. Typhimurium
0
tetC0
0
tetD0
0
tetG3
S. Typhimurium
2
S. Typhimurium
tetM1
MVST
0
Table 3. Primer and amplicon features of PCR assays used for tet gene characterization.
Table 3. Primer and amplicon features of PCR assays used for tet gene characterization.
Target GenePrimer SequenceAmplicon
Size (bp)
Tm (°C)Ref.
tetA5′-GTAATTCTGAGCACTGTCGC-3′95657[60]
5′-CTGCCTGGACAACATTGCTT-3′
tetB5′-CTCAGTATTCCAAGCCTTTG-3′41452[60]
5′-ACTCCCCTGAGCTTGAGGGG-3′
tetC5′-GGTTGAAGGCTCTCAAGGGC-3′50565[60]
5′-CCTCTTGCGGGATATCGTCC-3′
tetD5′-CATCCATCCGGAAGTGATAGC-3′43657[61]
5′-GGATATCTCACCGCATCTGC-3′
tetG5′-GCAGCGAAAGCGTATTTGCG-3′66262[62]
5′-TCCGAAAGCTGTCCAAGCAT-3′
tetM5′-GTTAAATAGTGTTCTTGGAG-3′65745[62]
5′-CTAAGATATGGCTCTAACAA-3′
Table 4. Positive control strains used for tet gene PCR-based characterisation provided by the European Reference Laboratory for Antimicrobial Resistance (EURL-AR, Technical University of Denmark, National Food Institute).
Table 4. Positive control strains used for tet gene PCR-based characterisation provided by the European Reference Laboratory for Antimicrobial Resistance (EURL-AR, Technical University of Denmark, National Food Institute).
SpeciesStrain Nametet Gene
E. colitetA, NCTC 50078tetA
E. colitetB, CSH50::Tn10tetB
E. colitetC DO7 pBR 322, TettetC
E. colitetD C600 psl 106, Tet
tetDx2
tetD
S. TyphimuriumP502212 DT104
sul1 and tetG
tetG
Staph. intermedius2567, chromosomal tetMtetM
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Russo, I.; Bencardino, D.; Napoleoni, M.; Andreoni, F.; Schiavano, G.F.; Baldelli, G.; Brandi, G.; Amagliani, G. Prevalence, Antibiotic-Resistance, and Replicon-Typing of Salmonella Strains among Serovars Mainly Isolated from Food Chain in Marche Region, Italy. Antibiotics 2022, 11, 725. https://doi.org/10.3390/antibiotics11060725

AMA Style

Russo I, Bencardino D, Napoleoni M, Andreoni F, Schiavano GF, Baldelli G, Brandi G, Amagliani G. Prevalence, Antibiotic-Resistance, and Replicon-Typing of Salmonella Strains among Serovars Mainly Isolated from Food Chain in Marche Region, Italy. Antibiotics. 2022; 11(6):725. https://doi.org/10.3390/antibiotics11060725

Chicago/Turabian Style

Russo, Ilaria, Daniela Bencardino, Maira Napoleoni, Francesca Andreoni, Giuditta Fiorella Schiavano, Giulia Baldelli, Giorgio Brandi, and Giulia Amagliani. 2022. "Prevalence, Antibiotic-Resistance, and Replicon-Typing of Salmonella Strains among Serovars Mainly Isolated from Food Chain in Marche Region, Italy" Antibiotics 11, no. 6: 725. https://doi.org/10.3390/antibiotics11060725

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop